U.S. market Closed. Opens in 3 hours 54 minutes

SGRY | Surgery Partners, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for SGRY we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is good and Health is weak.

Valuation (43%)

Company Industry
P/E Ratio (TTM) 531.02 28.17
PEG Ratio (TTM) -6.58 -0.78
P/S Ratio (TTM) 1.30 1.71
P/B Ratio (TTM) 1.90 2.51
P/FCF Ratio (TTM) 18.36 14.89
Price to 5YR AVG Earnings Ratio 52.46 22.20
Price to 5YR AVG FCF Ratio 32.71 21.36

Profitability (25%)

Company Industry
ROA (TTM) 0.09% 2.74%
ROE (TTM) 0.35% 29.50%
Net Profit Margin (TTM) 0.24% -1.89%
ROIC 5YR AVG 7.85% 16.57%

Growth (70%)

4QTR AVG 3YR AVG 5YR AVG
EPS -290.34% 1,198.47% 696.48%
Revenue 3.46% 8.19% 9.35%
Net Income -294.46% 1,787.90% 1,054.61%
Cash Flow 32.27% 5.16% 36.57%

Health (42%)

Company Industry
Current Ratio (TTM) 1.83 1.37
Quick Ratio (TTM) 1.69 1.21
D/E Ratio (TTM) 1.26 1.91
Interest Coverage (TTM) 3.82 16.10
Piotroski F-Score 4 7
Altman Z-Score 0.99 2.81
LTL to 5YR AVG FCF 17.76 7.48
Shares Outstanding Growth 5YR AVG 22.72% 20.92%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙